STABLE HELICAL IONIC POLYPEPTIDES
    2.
    发明授权
    STABLE HELICAL IONIC POLYPEPTIDES 有权
    稳定的螺旋离子多肽

    公开(公告)号:EP2646048B1

    公开(公告)日:2017-11-01

    申请号:EP11845856.1

    申请日:2011-11-30

    IPC分类号: A61K39/00

    摘要: The invention provides polymers comprising Formula I: wherein monomer is a repeating unit comprising 2, 3, 4, 5, 6 or 7 carbon atoms and the monomers are linked together through amide or ester bonds; n is about 6 to about 1000; and Linker is an optionally substituted carbon chain that is optionally interrupted by moieties such as oxygen, nitrogen, sulfur, phosphorus, or silicon. Charge is a moiety having a positive or negative charge on a heteroatom, such as nitrogen, oxygen, phosphorus, or sulfur; where the Linker separates the monomer and the Charge by at least six linear atoms. The invention also provides methods of preparing the polymers and the copolymers and methods of using the polymers and copolymers, for example, as drug delivery systems, as membrane penetrating peptides, and as therapeutic agents.

    STABLE HELICAL IONIC POLYPEPTIDES
    4.
    发明公开
    STABLE HELICAL IONIC POLYPEPTIDES 有权
    稳定的离子螺旋多肽

    公开(公告)号:EP2646048A2

    公开(公告)日:2013-10-09

    申请号:EP11845856.1

    申请日:2011-11-30

    IPC分类号: A61K39/00

    摘要: The invention provides polymers comprising Formula I: wherein monomer is a repeating unit comprising 2, 3, 4, 5, 6 or 7 carbon atoms and the monomers are linked together through amide or ester bonds; n is about 6 to about 1000; and Linker is an optionally substituted carbon chain that is optionally interrupted by moieties such as oxygen, nitrogen, sulfur, phosphorus, or silicon. Charge is a moiety having a positive or negative charge on a heteroatom, such as nitrogen, oxygen, phosphorus, or sulfur; where the Linker separates the monomer and the Charge by at least six linear atoms. The invention also provides methods of preparing the polymers and the copolymers and methods of using the polymers and copolymers, for example, as drug delivery systems, as membrane penetrating peptides, and as therapeutic agents.